VG Life Sciences Inc. (VGLS) Financials Nov 14, 20
Post# of 250675
Posted On: 11/17/2014 2:34:05 AM
VG Life Sciences Inc. (VGLS) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for VG Life Sciences Inc.
Fiscal year is January-December. All values USD millions. 2006 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 5,677 0 2,660 0
Cost of Goods Sold (COGS) incl. D&A 90,350 286,780 - - -
COGS excluding D&A 0 219,000 - - -
Depreciation & Amortization Expense 90,350 67,780 121,963 59,053 0
Depreciation 90,350 - - 0 0
Amortization of Intangibles - 0 - 59,053 0
Gross Income (90,350) (281,103) - - -
2006 2010 2011 2012 2013 5-year trend
SG&A Expense 6.29M 2.36M - 2.58M 3.76M
Research & Development 1.77M 498,606 - 345,126 563,141
Other SG&A 4.52M 1.86M - 2.23M 3.19M
Other Operating Expense 0 0 - 0 0
Unusual Expense 0 1.67M - 0 2.5M
EBIT after Unusual Expense 0 (1.67M) - 0 (2.5M)
Non Operating Income/Expense (2.25M) 0 0 0 0
Non-Operating Interest Income 4,845 - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 3.99M 2.93M 1.43M 2.83M 1.08M
Gross Interest Expense 3.99M 2.93M 1.43M 2.83M 1.08M
Interest Capitalized 0 0 - 0 0
Pretax Income (12.61M) (7.24M) (5.49M) (5.47M) (7.33M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income (12.61M) (7.24M) (5.49M) (5.47M) (7.33M)
Minority Interest Expense 0 0 (73,560) (72,759) (59,476)
Net Income (12.61M) (7.24M) (5.42M) (5.4M) (7.27M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (12.61M) (7.24M) (5.42M) (5.4M) (7.27M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (12.61M) (7.24M) (5.42M) (5.4M) (7.27M)
EPS (Basic) (72.00) (6.00) (6.00) (2.53) (0.89)
Basic Shares Outstanding 174,486 926,531 1.23M 2.14M 8.19M
EPS (Diluted) (72.00) (6.00) (6.00) (2.53) (0.89)
Diluted Shares Outstanding 174,486 926,531 1.23M 2.14M 8.19M
EBITDA (6.29M) (2.57M) (3.94M) (2.57M) (3.76M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for VG Life Sciences Inc.
Fiscal year is January-December. All values USD millions. 2006 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 5,677 0 2,660 0
Cost of Goods Sold (COGS) incl. D&A 90,350 286,780 - - -
COGS excluding D&A 0 219,000 - - -
Depreciation & Amortization Expense 90,350 67,780 121,963 59,053 0
Depreciation 90,350 - - 0 0
Amortization of Intangibles - 0 - 59,053 0
Gross Income (90,350) (281,103) - - -
2006 2010 2011 2012 2013 5-year trend
SG&A Expense 6.29M 2.36M - 2.58M 3.76M
Research & Development 1.77M 498,606 - 345,126 563,141
Other SG&A 4.52M 1.86M - 2.23M 3.19M
Other Operating Expense 0 0 - 0 0
Unusual Expense 0 1.67M - 0 2.5M
EBIT after Unusual Expense 0 (1.67M) - 0 (2.5M)
Non Operating Income/Expense (2.25M) 0 0 0 0
Non-Operating Interest Income 4,845 - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 3.99M 2.93M 1.43M 2.83M 1.08M
Gross Interest Expense 3.99M 2.93M 1.43M 2.83M 1.08M
Interest Capitalized 0 0 - 0 0
Pretax Income (12.61M) (7.24M) (5.49M) (5.47M) (7.33M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 - - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income (12.61M) (7.24M) (5.49M) (5.47M) (7.33M)
Minority Interest Expense 0 0 (73,560) (72,759) (59,476)
Net Income (12.61M) (7.24M) (5.42M) (5.4M) (7.27M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (12.61M) (7.24M) (5.42M) (5.4M) (7.27M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (12.61M) (7.24M) (5.42M) (5.4M) (7.27M)
EPS (Basic) (72.00) (6.00) (6.00) (2.53) (0.89)
Basic Shares Outstanding 174,486 926,531 1.23M 2.14M 8.19M
EPS (Diluted) (72.00) (6.00) (6.00) (2.53) (0.89)
Diluted Shares Outstanding 174,486 926,531 1.23M 2.14M 8.19M
EBITDA (6.29M) (2.57M) (3.94M) (2.57M) (3.76M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)